Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques

Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques

Item
http://www.wikidata.org/entity/Q27486549
Pathogenesis of human immunodeficiency virus infectionHuman immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines.Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linkedEnhanced in vitro human immunodeficiency virus type 1 replication in B cells expressing surface antibody to the TM Env protein.Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge.Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitroSuppression of measles virus expression by noncytolytic antibody in an immortalized macrophage cell line.A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.
P2860

Antibody-dependent enhancement of simian immunodeficiency virus (SIV) infection in vitro by plasma from SIV-infected rhesus macaques

Item
http://www.wikidata.org/entity/Q27486549
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@ast
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@en
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@nl
type
label
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@ast
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@en
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@nl
prefLabel
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@ast
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@en
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@nl
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P921
P932
P1433
P1476
Antibody-dependent enhancement ...... m SIV-infected rhesus macaques
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P921
P932